Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Moodys
Boehringer Ingelheim
Colorcon
AstraZeneca

Last Updated: December 6, 2021

Volunteer for clinical trials for MACROBID at ClinicalTrialExchange

DrugPatentWatch Database Preview

MACROBID Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Macrobid patents expire, and what generic alternatives are available?

Macrobid is a drug marketed by Almatica and is included in one NDA.

The generic ingredient in MACROBID is nitrofurantoin; nitrofurantoin, macrocrystalline. There are twenty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the nitrofurantoin; nitrofurantoin, macrocrystalline profile page.

Drug patent expirations by year for MACROBID
Drug Prices for MACROBID

See drug prices for MACROBID

Drug Sales Revenue Trends for MACROBID

See drug sales revenues for MACROBID

Recent Clinical Trials for MACROBID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Roswell Park Cancer InstitutePhase 4
National Cancer Institute (NCI)Phase 4
University of California, San DiegoN/A

See all MACROBID clinical trials

Pharmacology for MACROBID
Paragraph IV (Patent) Challenges for MACROBID
Tradename Dosage Ingredient NDA Submissiondate
MACROBID CAPSULE;ORAL nitrofurantoin; nitrofurantoin, macrocrystalline 020064

US Patents and Regulatory Information for MACROBID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Almatica MACROBID nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 020064-001 Dec 24, 1991 AB RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MACROBID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Almatica MACROBID nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 020064-001 Dec 24, 1991 ⤷  Free Forever Trial ⤷  Free Forever Trial
Almatica MACROBID nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 020064-001 Dec 24, 1991 ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Harvard Business School
McKesson
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.